Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zaneeta Dhesi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Lancet. Infectious Diseases|May 17, 2011
The HVTN 503/Phambili study: efficacy is always the issueZaneeta Dhesi, Justin Stebbing
BMJ Case Reports|May 25, 2019
Death by antibodyTimothy Faccini, Zaneeta Dhesi, Sachin Shah
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2012
Transcript profiling of the murine immune response to invasive aspergillosisZaneeta Dhesi, Susanne Herbst, Darius Armstrong-James
ACS Pharmacology & Translational Science|June 20, 2020
Rapid and Point-of-Care Testing in Respiratory Tract Infections: An Antibiotic Guardian?Zaneeta Dhesi, Virve I Enne, Justin O'Grady, et al.
Travel Medicine and Infectious Disease|March 12, 2019
Zika virus infection in travellers returning to the United Kingdom during the period of the outbreak in the Americas (2016-17): A retrospective analysisChristina Petridou, Andrew Simpson, Andre Charlett, et al.
Trials|October 8, 2021
INHALE: the impact of using FilmArray Pneumonia Panel molecular diagnostics for hospital-acquired and ventilator-associated pneumonia on antimicrobial stewardship and patient outcomes in UK Critical Care-study protocol for a multicentre randomised controlled trialJuliet High, Virve I Enne, Julie A Barber, et al.
Intensive Care Medicine|February 17, 2025
INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumoniaVirve I Enne, Susan Stirling, Julie A Barber, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Lancet. Infectious Diseases|May 17, 2011
The HVTN 503/Phambili study: efficacy is always the issueZaneeta Dhesi, Justin Stebbing
BMJ Case Reports|May 25, 2019
Death by antibodyTimothy Faccini, Zaneeta Dhesi, Sachin Shah
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2012
Transcript profiling of the murine immune response to invasive aspergillosisZaneeta Dhesi, Susanne Herbst, Darius Armstrong-James
ACS Pharmacology & Translational Science|June 20, 2020
Rapid and Point-of-Care Testing in Respiratory Tract Infections: An Antibiotic Guardian?Zaneeta Dhesi, Virve I Enne, Justin O'Grady, et al.
Travel Medicine and Infectious Disease|March 12, 2019
Zika virus infection in travellers returning to the United Kingdom during the period of the outbreak in the Americas (2016-17): A retrospective analysisChristina Petridou, Andrew Simpson, Andre Charlett, et al.
Trials|October 8, 2021
INHALE: the impact of using FilmArray Pneumonia Panel molecular diagnostics for hospital-acquired and ventilator-associated pneumonia on antimicrobial stewardship and patient outcomes in UK Critical Care-study protocol for a multicentre randomised controlled trialJuliet High, Virve I Enne, Julie A Barber, et al.
Intensive Care Medicine|February 17, 2025
INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumoniaVirve I Enne, Susan Stirling, Julie A Barber, et al.
Pageof 1